showed a trendP = 0.002
Those who received chemotherapy also showed a trend for receiving tamoxifen (43.1% vs. 34.6%, P = 0.002).
Those who received chemotherapy also showed a trend for receiving tamoxifen (43.1% vs. 34.6%, P = 0.002).
In the current study, RS of 26 also displayed a marginally significant interaction with chemotherapy.